The ARISCAT Risk Index as a Predictor of Pulmonary Complications After Thoracic Surgeries, Almoosa Specialist Hospital, Saudi Arabia.
ARISCAT score
atelectasis
pneumonia
postoperative complications
pulmonary complications
thoracic surgery
Journal
Journal of multidisciplinary healthcare
ISSN: 1178-2390
Titre abrégé: J Multidiscip Healthc
Pays: New Zealand
ID NLM: 101512691
Informations de publication
Date de publication:
2023
2023
Historique:
received:
23
01
2023
accepted:
28
02
2023
entrez:
13
3
2023
pubmed:
14
3
2023
medline:
14
3
2023
Statut:
epublish
Résumé
Pulmonary complications after thoracic surgery are common and are associated with prolonged hospital stay, higher costs, and increased mortality. This study aimed to evaluate the value of The Assess Respiratory risk in Surgical Patients in Catalonia (ARISCAT) risk index in predicting pulmonary complications after thoracic surgery. This retrospective study was conducted at Almoosa Specialist Hospital, Saudi Arabia, from August 2016 to August 2019 and included 108 patients who underwent thoracic surgery during the study period. Demographic data, ARISCAT risk index score, length of hospital stay, time of chest tube removal, postoperative complications, and time of discharge were recorded. The study involved 108 patients who met the inclusion criteria. Their mean age was 42.5 ± 18.9 years, and most of them were men (67.6%). Comorbid diseases were present in 53.7%, including mainly type 2 diabetes mellitus and hypertension. FEV1% was measured in 58 patients, with a mean of 71.1 ± 7.3%. The mean ARISCAT score was 39.3 ± 12.4 and ranged from 24 to 76, with more than one-third (35.2%) having a high score grade. The most common surgical procedures were thoracotomy in 47.2%, video-assisted thoracoscopic surgery (VATS) in 28.7%, and mediastinoscopy in 17.6%. Postoperative pulmonary complications (PPCs) occurred in 22 patients (20.4%), mainly pneumonia and atelectasis (9.2%). PPCs occurred most frequently during thoracotomy (68.2%), followed by VATS (13.6%), and mediastinoscopy (9.1%). Multinomial logistic regression of significant risk factors showed that lower FEV1% (OR = 0.88 [0.79-0.98]; p=0.017), longer ICU length of stay (OR = 1.53 [1.04-2.25]; p=0.033), a higher ARISCAT score (OR = 1.22 [1.02-1.47]; p=0.040), and a high ARISCAT grade (OR = 2.77 [1.06-7.21]; p=0.037) were significant predictors of the occurrence of postoperative complications. ARISCAT scoring system, lower FEV1% score, and longer ICU stay were significant predictors of postoperative complications. In addition, thoracotomy was also found to be associated with PPCs.
Sections du résumé
Background
UNASSIGNED
Pulmonary complications after thoracic surgery are common and are associated with prolonged hospital stay, higher costs, and increased mortality. This study aimed to evaluate the value of The Assess Respiratory risk in Surgical Patients in Catalonia (ARISCAT) risk index in predicting pulmonary complications after thoracic surgery.
Methods
UNASSIGNED
This retrospective study was conducted at Almoosa Specialist Hospital, Saudi Arabia, from August 2016 to August 2019 and included 108 patients who underwent thoracic surgery during the study period. Demographic data, ARISCAT risk index score, length of hospital stay, time of chest tube removal, postoperative complications, and time of discharge were recorded.
Results
UNASSIGNED
The study involved 108 patients who met the inclusion criteria. Their mean age was 42.5 ± 18.9 years, and most of them were men (67.6%). Comorbid diseases were present in 53.7%, including mainly type 2 diabetes mellitus and hypertension. FEV1% was measured in 58 patients, with a mean of 71.1 ± 7.3%. The mean ARISCAT score was 39.3 ± 12.4 and ranged from 24 to 76, with more than one-third (35.2%) having a high score grade. The most common surgical procedures were thoracotomy in 47.2%, video-assisted thoracoscopic surgery (VATS) in 28.7%, and mediastinoscopy in 17.6%. Postoperative pulmonary complications (PPCs) occurred in 22 patients (20.4%), mainly pneumonia and atelectasis (9.2%). PPCs occurred most frequently during thoracotomy (68.2%), followed by VATS (13.6%), and mediastinoscopy (9.1%). Multinomial logistic regression of significant risk factors showed that lower FEV1% (OR = 0.88 [0.79-0.98]; p=0.017), longer ICU length of stay (OR = 1.53 [1.04-2.25]; p=0.033), a higher ARISCAT score (OR = 1.22 [1.02-1.47]; p=0.040), and a high ARISCAT grade (OR = 2.77 [1.06-7.21]; p=0.037) were significant predictors of the occurrence of postoperative complications.
Conclusion
UNASSIGNED
ARISCAT scoring system, lower FEV1% score, and longer ICU stay were significant predictors of postoperative complications. In addition, thoracotomy was also found to be associated with PPCs.
Identifiants
pubmed: 36910018
doi: 10.2147/JMDH.S404124
pii: 404124
pmc: PMC9999721
doi:
Types de publication
Journal Article
Langues
eng
Pagination
625-634Informations de copyright
© 2023 Eldaabossi et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Indian J Anaesth. 2015 Sep;59(9):618-26
pubmed: 26556921
Int J Med Sci. 2014 Jun 11;11(9):863-9
pubmed: 25013365
Ann Thorac Surg. 2015 May;99(5):1761-7
pubmed: 25818569
J Anaesthesiol Clin Pharmacol. 2020 Jan-Mar;36(1):88-93
pubmed: 32174665
Ann Thorac Surg. 2008 Feb;85(2):S719-28
pubmed: 18222204
J Thorac Dis. 2016 Jun;8(6):1210-6
pubmed: 27293839
Anesthesiology. 2011 Jul;115(1):44-53
pubmed: 21552116
Br J Anaesth. 2017 Mar 1;118(3):317-334
pubmed: 28186222
Anesthesiology. 2010 Dec;113(6):1338-50
pubmed: 21045639
J Clin Med. 2022 Sep 29;11(19):
pubmed: 36233649
Asian Cardiovasc Thorac Ann. 2019 May;27(4):278-287
pubmed: 30857395
Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):931-937
pubmed: 28329213
Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):244-9
pubmed: 23169877
Ann Thorac Surg. 2002 Oct;74(4):999-1003
pubmed: 12400735
Physiotherapy. 2011 Dec;97(4):278-83
pubmed: 22051583
Thorax. 2010 Sep;65(9):815-8
pubmed: 20805178
Anesthesiology. 2014 Aug;121(2):219-31
pubmed: 24901240
Am J Surg. 2013 Oct;206(4):544-50
pubmed: 23880071
Thorac Cancer. 2021 Dec;12(23):3255-3262
pubmed: 34693656
Medicine (Baltimore). 2022 Jul 29;101(30):e29723
pubmed: 35905198
Ann Thorac Surg. 2010 Apr;89(4):1044-51; discussion 1051-2
pubmed: 20338305
J Thorac Cardiovasc Surg. 2010 Apr;139(4):976-81; discussion 981-3
pubmed: 20172539
Eur J Cardiothorac Surg. 2016 Mar;49(3):870-5
pubmed: 26088592
Eur J Anaesthesiol. 2015 Feb;32(2):88-105
pubmed: 25058504
Thorax. 2016 Feb;71(2):171-6
pubmed: 26769017
J Thorac Cardiovasc Surg. 2015 Jan;149(1):314-20, 321.e1
pubmed: 25304302
Braz J Anesthesiol. 2021 Jul-Aug;71(4):333-338
pubmed: 34229858
J Thorac Dis. 2018 Nov;10(11):6020-6029
pubmed: 30622773
J Thorac Dis. 2017 May;9(5):1219-1225
pubmed: 28616271
J Thorac Cardiovasc Surg. 2009 Aug;138(2):419-25
pubmed: 19619789
J Surg Res. 2014 Dec;192(2):628-34
pubmed: 25167779